29 June
The HMDS Annual Haematopathology Update: Incorporating novel diagnostics into patient management

Royal Armouries International, 5 Armouries Drive, Leeds, LS10 1LT

Registration fee: £36 (£30 + VAT)

Organisers – HMDS; Cathy Burton, Ruth de Tute, Roger Owen, Gordon Cook and colleagues.
Plus a selection of UK speakers to give a comprehensive faculty of speakers to look at the patient pathways from laboratory to bedside.


Guest Speaker:
Professor Sue Hill OBE, NHS Chief Scientific Officer for England

Overview of Lymphoma Management – Professor David Linch, UCLH

Acute leukaemia
Diagnostics in ALL – Dr Pedro Martin Cabrera, HMDS Leeds
Current clinical aspects of ALL – Dr Clare Rowntree, Cardiff

High-grade DLBCL (Burkitt’s, Double and Triple-hit)
…..other lymphomas benefiting from better patient pathways
Bioinformatics – Prof David Westhead, University of Leeds
High Grade DLBCL patient management – Dr Wendy Osborne, Newcastle

Diagnostics, Risk factors, genetics & novel antibodies in CLL – Dr Claire Dearden, Royal Marsden Hospital

Next generation sequencing in CML – Dr Hugues de Lavallade, King’s College Hospital

Diagnostics and prognostic markers in myeloma – Dr Polly Talley, HMDS Leeds
Novel agents and high dose chemotherapy in myeloma – Dr Matthew Jenner, Southampton

To book stand space or for further details on the meeting with a view to attend please contact Steph@hartleytaylor.co.uk

Hartley Taylor Medical Communications Ltd
Caledonian House | Tatton Street
Knutsford | Cheshire | WA16 6AG
Tel: ++44 (0)1565 621967